282 related articles for article (PubMed ID: 27473450)
1. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study.
Goldenberg G; Karagiannis T; Palmer JB; Lotya J; O'Neill C; Kisa R; Herrera V; Siegel DM
J Am Acad Dermatol; 2016 Nov; 75(5):957-966.e2. PubMed ID: 27473450
[TBL] [Abstract][Full Text] [Related]
2. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
4. Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014.
Migden M; Xie J; Wei J; Tang W; Herrera V; Palmer JB
J Am Acad Dermatol; 2017 Jul; 77(1):55-62.e3. PubMed ID: 28392293
[TBL] [Abstract][Full Text] [Related]
5. Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia.
Mesti T; Sever M; Ocvirk J
Dermatology; 2023; 239(1):158-164. PubMed ID: 35896082
[TBL] [Abstract][Full Text] [Related]
6. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010.
Nguyen-Nielsen M; Wang L; Pedersen L; Olesen AB; Hou J; Mackey H; McCusker M; Basset-Seguin N; Fryzek J; Vyberg M
Eur J Dermatol; 2015; 25(5):463-8. PubMed ID: 26105129
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
8. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
Sekulic A; Migden MR; Lewis K; Hainsworth JD; Solomon JA; Yoo S; Arron ST; Friedlander PA; Marmur E; Rudin CM; Chang AL; Dirix L; Hou J; Yue H; Hauschild A;
J Am Acad Dermatol; 2015 Jun; 72(6):1021-6.e8. PubMed ID: 25981002
[TBL] [Abstract][Full Text] [Related]
9. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
[TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of epilepsy in the U.S. population: A different approach.
Helmers SL; Thurman DJ; Durgin TL; Pai AK; Faught E
Epilepsia; 2015 Jun; 56(6):942-8. PubMed ID: 25921003
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Stern RS
Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
[TBL] [Abstract][Full Text] [Related]
12. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area.
Bielsa I; Soria X; Esteve M; Ferrándiz C;
Br J Dermatol; 2009 Dec; 161(6):1341-6. PubMed ID: 19796178
[TBL] [Abstract][Full Text] [Related]
13. U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma.
Axelson M; Liu K; Jiang X; He K; Wang J; Zhao H; Kufrin D; Palmby T; Dong Z; Russell AM; Miksinski S; Keegan P; Pazdur R
Clin Cancer Res; 2013 May; 19(9):2289-93. PubMed ID: 23515405
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns and outcomes for patients with locally advanced basal cell carcinoma before availability of Hedgehog pathway inhibitors: a retrospective chart review.
Lear JT; Basset-Seguin N; Kaatz M; Jouary T; Mortier L; Fabrizio T; Herd R; Leverkus M; Revil C; Page DR; Grob JJ
Eur J Dermatol; 2017 Aug; 27(4):386-392. PubMed ID: 28862133
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010.
Muzic JG; Schmitt AR; Wright AC; Alniemi DT; Zubair AS; Olazagasti Lourido JM; Sosa Seda IM; Weaver AL; Baum CL
Mayo Clin Proc; 2017 Jun; 92(6):890-898. PubMed ID: 28522111
[TBL] [Abstract][Full Text] [Related]
16. Age distribution of patients with advanced non-melanoma skin cancer in the United States.
Dacosta Byfield S; Chen D; Yim YM; Reyes C
Arch Dermatol Res; 2013 Nov; 305(9):845-50. PubMed ID: 23604961
[TBL] [Abstract][Full Text] [Related]
17. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States.
Cosmatos I; Matcho A; Weinstein R; Montgomery MO; Stang P
J Am Acad Dermatol; 2013 Mar; 68(3):412-9. PubMed ID: 22921795
[TBL] [Abstract][Full Text] [Related]
18. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma of the eyelid in Finland during 1953-97.
Paavilainen V; Tuominen J; Pukkala E; Saari KM
Acta Ophthalmol Scand; 2005 Apr; 83(2):215-20. PubMed ID: 15799736
[TBL] [Abstract][Full Text] [Related]
20. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.
Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK
JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
